Ferring Pharmaceuticals Inc

4 FDA enforcement actions

4 Total Recalls

0 Class I

3 Class II

1 Class III

Firm Details

Product Types: drug
States: NJ

All Recalls

Class II: Risk 06/12/2023 drug

cGMP deviations: potential for Microbial Contamination of Non-Sterile Products
Class II: Risk 03/11/2021 drug

Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces.
Class II: Risk 03/11/2021 drug

Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces.
Class III: Low Risk 03/02/2021 drug

Failed pH specifications: Out of Specification pH results for 0.9% Sodium Chloride, USP

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.